[PERSON]
Tirzepatide
Featured in 1 tracked story · first seen
Situations
GLP‑1 weight‑loss drugs: safety, policy and clinical rollout
185 clusters · 671 sources · last updated
Latest: GLP‑1 weight‑loss drugs drive new workplace benefits, retail battles and safety debates
Since mid‑2026, the rapid expansion of GLP‑1 agents for obesity has been accompanied by growing emphasis on complementary diet, insurance constraints and emerging safety signals. Clinical experts in the United States and